Skip to main content
DNA Labs India

GFPT1 Gene Myasthenia congenital with tubular aggregates 1 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

GFPT1 Gene Myasthenia congenital with tubular aggregates 1 NGS Genetic Test

Short Name: GFPT1 NGS Genetic Test

Also known as: GFPT1 Gene Myasthenia Congenital NGS Test, MCTA1 Genetic Test

GFPT1 Gene Myasthenia congenital with tubular aggregates 1 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood, Extracted DNA, Saliva or one drop blood on FTA card samples. Results in Reports are typically delivered within 3 to 4 weeks after the sample is received by the laboratory.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to confirm the diagnosis of Myasthenia Congenital with Tubular Aggregates 1 (MCTA1) by detecting mutations in the GFPT1 gene using Next-Generation Sequencing (NGS) technology.

Test Code
4369
Price
₹20,000
Sample Type
Blood, Extracted DNA, Saliva or one drop blood on FTA card
Result Time
Reports are typically delivered within 3 to 4 weeks after the sample is received by the laboratory.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

Clinical history of the patient must be provided. A genetic counselling session to draw a pedigree chart of family members affected with MCTA1 is recommended. No special preparation such as fasting is required.

Method: Venipuncture, saliva collection or FTA card blood spot

Step 2

Laboratory Analysis

A blood sample is collected by venipuncture, a saliva sample is collected in a sterile tube, or a few drops of blood are placed on an FTA card.

Step 3

Report Delivery

No specific post-test precautions are required. Reports will be available within 3 to 4 weeks.

Timeline: Reports are typically delivered within 3 to 4 weeks after the sample is received by the laboratory.

Patient Instructions

1
Before the Test:No special preparation is required for this test. Please carry any relevant clinical history and doctor's prescription. A genetic counselling session is recommended.
2
During the Test:A healthcare professional will collect a blood sample or guide you in providing a saliva sample or FTA card spot. The process is quick and minimally invasive.
3
After the Test:You may resume normal activities immediately. Your genetic counsellor or physician will discuss the results with you once available.

About This Test

Who Should Get This Test

The purpose of this test is to confirm the diagnosis of Myasthenia Congenital with Tubular Aggregates 1 (MCTA1) by detecting mutations in the GFPT1 gene using Next-Generation Sequencing (NGS) technology.

How to Prepare

  • Blood sample via venipuncture or FTA card blood spot
  • Saliva sample in a sterile collection tube
  • Genetic counselling session is recommended before the test

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Early genetic diagnosis of MCTA1 helps in appropriate treatment planning and family counselling."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood, Extracted DNA, Saliva or one drop blood on FTA card
Collection MethodVenipuncture, saliva collection or FTA card blood spot
Sample Rejection Criteria:
  • Clotted blood sample
  • Hemolyzed sample
  • Incorrectly labelled sample

Understanding Your Results

The results of this NGS genetic test will indicate whether a pathogenic mutation in the GFPT1 gene is present.
📊

Positive

A pathogenic or likely pathogenic variant was detected in the GFPT1 gene, confirming the diagnosis of MCTA1.

📊

Negative

No pathogenic variants were detected in the GFPT1 gene. Other genetic causes may still be considered.

📊

Variant of Uncertain Significance (VUS)

A variant was found but its clinical significance is unclear. Additional analysis or family studies may be recommended.

⚠️ When to Consult a Doctor:

Consult a neurologist if you experience muscle weakness, fatigue, difficulty swallowing, or breathing problems suggestive of a congenital myasthenic syndrome.

Limitations

  • This test only analyses the GFPT1 gene; other genes involved in congenital myasthenic syndromes are not evaluated
  • NGS may not detect large structural rearrangements or repeat expansions

Risks & Considerations

  • Minimal risk of minor pain or bruising at the blood draw site

Interfering Factors

  • Sample degradation or contamination
  • Insufficient DNA quantity
  • Previously known non-pathogenic variants
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.